focus -WSS

focus

author：focus 2025-09-03 14:37:51 - browse：1622

Cheryl Meier had watched clinical trial enrollment announcements for years — but always for her sons’ type 1 diabetes, never for herself. Her OB-GYN had put her on Effexor for her depression 20 years ago, and it worked well enough — she could sleep for the first time in her life, and she no longer cried at every little thing. But it never worked for her dark thoughts.

But then she retired, and then she had time, and then she saw an email — “I guess once your name gets on a list, it’s there,” she said — for an experimental depression drug called zuranolone.

Unlike today’s crowded market of SSRIs, prescribed once and taken for months, years, or even indefinitely, zuranolone, developed by Sage Therapeutics, promises something different.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： ACA's risk program benefits Blue Cross Blue Shield insurers

WSS

Akili, maker of video game for ADHD, to be acquired for 34 million

Adam's Biotech Scorecard: Do Sarepta's exon

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

iTeos Therapeutics debuts first data on TIGIT

Latest bird flu infection made farmworker sicker than earlier cases

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

hotspot

focus

Wikipedia

Peter Hotez and the public health issue of online harassment

Presidential fundraising highlights so far: Trump brings in more than DeSantis

At least 13 dead in Texas as scorching temps continue

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Duchenne breakthrough therapy leaves behind pioneering families

Biohaven protein

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Prosthetic arm enables patients to feel the objects they grip

After affirmative action ruling, medical educators look to 'holistic review'

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

leisure time

Do more moles mean more problems? Not so, says new study

Akili, maker of video game for ADHD, to be acquired for 34 million

Home health providers sue Medicare over payment cuts

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Pandemic and All Hazards Preparedness Act needs lean update

hotspot

hotspot

explore

focus